In the BioHarmony Drug Report Database

"Preview" Icon

Teniposide

Vumon (teniposide) is a small molecule pharmaceutical. Teniposide was first approved as Vumon on 1992-07-14. It is used to treat lung neoplasms, lymphoid leukemia, and small cell carcinoma in the USA. It is known to target DNA topoisomerase 2-alpha.

 

Trade Name

 

Vumon
 

Common Name

 

teniposide
 

ChEMBL ID

 

CHEMBL452231
 

Indication

 

lung neoplasms, lymphoid leukemia, small cell carcinoma
 

Drug Class

 

Image (chem structure or protein)

Teniposide structure rendering